This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Knowing when and how to adjust your budget can keep you financially stable. Learn key indicators and methods for budget adjustments.
28,408 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Microsoft stock is drawing fresh attention as investors weigh AI demand against execution risk. With a trailing P/E n...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
TAO jumps more than 10% in a single session as Bitcoin targets $72,000. The move sets the tone for a weekend of volat...
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...